skip to Main Content
Canada’s Drug Stores Want In On Weed

Shopper’s Drug Mart, one of Canada’s most established retail brands, has formally applied to become licensed as a producer for Canada’s medical marijuana industry. The pharmacy chain, with over 1,200 locations, made its distribution ambitions very clear in a statement.

“We have no intention of producing medical marijuana, but we do want the ability to dispense medical marijuana to our patients in conjunction with counselling from a pharmacist.”

The move has been seen as a mandatory step for the company to initiate movement toward a distribution-only status. While a British Columbia judge ruled that medical patients can grow their own medical supply last February, retail distribution of cannabis is still illegal, despite countless dispensaries operating across the country.

The timing is interesting as the Liberal government is poised to receive a report from Anne McLellan’s Marijuana Task Force. This report will likely be considered a jumping point and initial framework for legislation that Trudeau’s Liberals intend on tabling before Parliament this coming spring. It may seem as though major pharmaceutical retailers have recognized the urgency to lobby their influence within the legislative process.

Alongside political timeliness is a ballooning Canadian market with 75,166+ medical marijuana patients registered with Health Canada. That number has grown by over 40% in the last quarter alone, and has more than tripled since last year.

In a reaction to this patient growth, it’s been reported that a number of Shopper’s Drug Mart competitors have also contacted a larger-scale Canadian producer with supply chain inquiries. Shopper’s largest competitor, Rexall, has been floated as a retailer of interest in the space, but company representatives have denied these claims.

Even the Canadian Pharmacists Association has come to change it’s tune from 2013, where it expressed great concern over the ‘lack of evidence’ supporting the use of medical marijuana. Suddenly, the association is campaigning to secure a ‘front-line role’ in the retail distribution of cannabis. What a difference a few years make.

As the retail segment lobbies to insert itself within a legislated supply chain, licensed producers are now expressing their concerns over retail counter-fees that will be passed to patients, as well as limited access to strain varieties for patients. The CMCIA has also called the retail pharmacists ability to serve patients with the insight and knowledge growers can offer patients regarding the use of particular strains into question.

Jonathan Zaid, founder and lobbyist for Canadians for Fair Access to Medical Marijuana, has been promoting the notion that the question of distribution is not one of absolutes, but includes an array of solutions that would deter patients from reaching out to black market means for access to medicine.

He said, “There needs to be a regulated legal source that patients can go to in person, and that just doesn’t exist today.” [Read More @Goodleaf]

 

This Post Has 0 Comments

Leave a Reply

Your email address will not be published.

Recent Stories

Lawmaker’s sick day causes recreational marijuana bill to fail by 1 vote in Delaware House

The pursuit to create a recreational marijuana industry in Delaware hit a bump on Thursday, as a bill seeking to regulate the growing and selling of weed failed in the House by one vote. Rep. Larry Mitchell, House majority whip, was ill and could not vote, said House spokesman Drew Volturo. Mitchell is a co-sponsor of…

Op-Ed: Why legal weed is losing the war to illegal weed

The market for legal weed is growing. But in California, as elsewhere, it faces serious challenges. We’re not talking about droughts, climate change or supply chain shortages. The biggest challenge is competition from illegal weed. Our best estimate is that roughly three-quarters of the weed currently sold to consumers in California is illegal (meaning it…

Marijuana labeling system “not an effective or safe way” to detail what’s inside the products, CU study finds

Researchers analyzed labels on 90,000 cannabis products and found them unreliable in describing chemical compounds consumers inhale Marijuana product labels fail to capture “the chemical reality” of what people smoke, a University of Colorado study has concluded after analyzing 90,000 samples offered for sale in six states. The widely used labeling system purported to predict…

Congress might have inadvertently legalized a form of cannabis under Trump

Although marijuana remains strictly forbidden by federal law, a federal appeals court ruled Thursday that Congress quietly amended the statute in 2018 to legalize cannabis cigarettes and vaping products that have similar intoxicants but are made from hemp. The 2018 Farm Bill, signed by President Donald Trump, included provisions removing most legal restrictions on hemp,…

More Categories

Back To Top
×Close search
Search